ArticleJournal of the American Heart Association2022

Contemporary National Patterns of Eligibility and Use of Novel Lipid-Lowering Therapies in the United States.

Miles Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.